MBXBFMicrobix Biosystems Inc.

About Microbix Biosystems Inc. (MBXBF)

Microbix Biosystems Inc. (MBXBF) is a Biotechnology company headquartered in Mississauaga, ON, Canada whose shares trade over-the-counter on the OTCQX tier.

Microbix develops proprietary biological technology solutions for human health and well-being, with about 130 skilled employees and sales growing from a base of over $1.5 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows. Microbix antigens are purchased by over 100 international test-makers, while its QAPs are sold to lab accreditation organizations, diagnostics companies, and clinical labs in over 30 countries via a network of eight regional distributors. Microbix is ISO 9001 and 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE marked products. Microbix also applies its biological expertise and infrastructure to develop other proprietary products, most notably viral transport medium (DxTM) to stabilize patient samples for lab-based testing and Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots. Microbix is traded on the TSX and OTCQB, and headquartered in Mississauga, Ontario, Canada.

Products and services

Microbix Biosystems Inc. specializes in developing biological and technology solutions for human health and well-being. It manufactures a wide range of critical biological materials for the global diagnostics industry in three categories, (1) antigens as ingredients for making infectious disease tests (Tests) and (2) as quality assessment products (QAPs™) for helping control Test accuracy, and (3) viral transport media (VTM) to enable patient-sampling for Tests.

MBXBF key facts

Ticker symbol

MBXBF

Market tier

OTCQX

Sector

Healthcare

Industry

Biotechnology

Headquarters

Mississauaga, ON, Canada

Country of incorporation

CA

Year of incorporation

1990

Employees

130

Estimated market cap

$35.96M (as of Apr 11, 2025)

Shares outstanding

141,031,726

Reporting standard

International Reporting: Toronto Stock Exchange

Audit status

Audited

Fiscal year end

9/30

Latest filing

Interim Financial Report (Dec 31, 2024)

Microbix Biosystems Inc. leadership

• Cameron Lionel Groome — President, CEO
• Kenneth Hughes — COO
• Jim Currie — CFO
• Deborah Honig — IR

Explore more: Biotechnology stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with M